Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-03 4:18 pm Unchanged | 13D | Artiva Biotherapeutics Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 40.6% | 0 (Unchanged) | View |
| 2024-08-01 7:00 pm Purchase | 13G | Artiva Biotherapeutics Inc. ARTV | venBio Global Strategic Fund III L.P. | 1,818,595 7.8% | 1,818,595 (New Position) | View |
| 2024-08-01 4:18 pm Purchase | 13G | Artiva Biotherapeutics Inc. ARTV | Venrock Healthcare Capital Partners III L.P. | 1,609,569 6.9% | 1,609,569 (New Position) | View |
| 2024-08-01 4:17 pm Purchase | 13G | Artiva Biotherapeutics Inc. ARTV | 5AM Ventures VI L.P. | 2,353,304 10.1% | 2,353,304 (New Position) | View |
| 2024-07-29 4:29 pm Purchase | 13D | Artiva Biotherapeutics Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 42.3% | 9,853,302 (New Position) | View |
| 2024-07-29 4:15 pm Purchase | 13D | Artiva Biotherapeutics Inc. ARTV | GC Corp. | 4,567,412 19.6% | 4,567,412 (New Position) | View |